Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMS MedisurgiBOM:540468 79 ROA % is 0.25% as of Mar. 2026, which is 89% below its 10-year median of 2.30. GuruFocus rates BOM:540468 with a GF Score™ of 79/100 and a GF Value™ of ₹111.50 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 856 Medical Devices & Instruments companies, KMS Medisurgi ranks better than 57.59% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. KMS Medisurgi's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹0.3 Mil.
KMS Medisurgi's average Total Assets over the quarter that ended in Mar. 2026 was ₹113.6 Mil. Therefore, KMS Medisurgi's annualized ROA % for the quarter that ended in Mar. 2026 was 0.25%.
The historical rank and industry rank for KMS Medisurgi's ROA % or its related term are showing as below:
BOM:540468'
s ROA % Range Over the Past 10 Years
Min: 1.02 Med: 2.3 Max: 5.86
Current: 2.23
During the past 13 years, KMS Medisurgi's highest ROA % was 5.86%. The lowest was 1.02%. And the median was 2.30%.
BOM:540468's ROA % is ranked better than 57.59% of 856
companies
in the Medical Devices & Instruments industry
Industry Median: 0.555
vs BOM:540468: 2.23
KMS Medisurgi (BOM:540468) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
KMS Medisurgi ROA % Related Terms
KMS Medisurgi ROA % Historical Data
* Premium members only.
The historical data trend for KMS Medisurgi's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, KMS Medisurgi's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMS Medisurgi ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KMS Medisurgi's ROA % distribution charts can be found below:
* The bar in red indicates where KMS Medisurgi's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
KMS Medisurgi (BOM:540468) has a ROA % of 0.25% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on KMS Medisurgi and its competitors. This is 89% below median its historical median of 2.30. Over the past decade, KMS Medisurgi's ROA % has ranged from 1.02 to 5.86. According to the industry distribution chart, KMS Medisurgi ranks #363 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 42.4%.
Is KMS Medisurgi's ROA % too high?
KMS Medisurgi's current ROA % of 0.25% is 89% below median its 10-year median of 2.30. Over the past 10 years, this metric has ranged from a low of 1.02 to a high of 5.86. The Medical Devices & Instruments industry median ROA % is 0.56. KMS Medisurgi's value of 0.25% is 55% below this industry median. Based on the distribution chart, KMS Medisurgi ranks #363 out of 856 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, KMS Medisurgi has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KMS Medisurgi ranks #363 out of 856 companies for ROA %. This puts KMS Medisurgi in the upper half of its industry. The industry median ROA % is 0.56. KMS Medisurgi's value of 0.25% is 55% below this benchmark. Historically, KMS Medisurgi's own ROA % has ranged from 1.02 to 5.86 over the past decade. While the company's 10-year median is 2.30 vs. the industry median of 0.56, KMS Medisurgi has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.56, based on 856 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMS Medisurgi's current ROA % of 0.25% is 55% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on KMS Medisurgi and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMS Medisurgi's current ROA % is 0.25%, which is 89% below median its own 10-year median of 2.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
Based on GuruFocus' analysis, KMS Medisurgi (BOM:540468) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹111.50, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current ROA % is 0.25%, which is 89% below median its 10-year median of 2.30 and 55% below the Medical Devices & Instruments industry median of 0.56. KMS Medisurgi's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current ROA % is 0.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMS Medisurgi (BOM:540468) Overvalued in 2026?
Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued.
The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.50.
GuruFocus considers KMS Medisurgi to be Modestly Overvalued.
Key valuation signals for BOM:540468:
ROA %: 0.25% (89% below median its 10-year median of 2.30)
GF Value™: ₹111.50 vs. price of ₹132.80 (19.1% above fair value)
Industry Position: 55% below the Medical Devices & Instruments median (#363 of 856)
No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score
Get the complete analysis for BOM:540468
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540468 has been successfully added to your 
